Straits Times Index
3,112.32 -17.92 (-0.57%) S&P 500
3,585.62 -54.85 (-1.51%) Dow
28,725.51 -500.09 (-1.71%) Nasdaq
10,575.62 -161.88 (-1.51%) BTC-USD
19,176.94 -107.61 (-0.56%) CMC Crypto 200
435.55 -7.88 (-1.78%)
Aditxt, Inc. (ADTX)
Pre-market:
- Zacks
Is the Options Market Predicting a Spike in Aditx (ADTX) Stock?
Investors need to pay close attention to Aditx (ADTX) stock based on the movements in the options market lately.
- Business Wire
Aditxt, Inc. (NASDAQ: ADTX) Announces That it Has Regained Compliance with Nasdaq Listing Requirements
RICHMOND, Va., September 29, 2022--Aditxt, Inc. (NASDAQ: ADTX) ("Aditxt" or the "Company"), a biotech innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system, today announces it has received confirmation from The Nasdaq Stock Market LLC Hearing Panel ("Nasdaq") that it has regained compliance with the minimum bid price requirement of $1.00 per share under Nasdaq Listing Rule 5550(a)(2), meets the stockholders’ equity requirement
- Business Wire
Aditxt Inc. (Nasdaq: ADTX) Provides Corporate Highlights Post Reverse Stock Split and Closing of $20M Public Offering
RICHMOND, Va., September 27, 2022--Aditxt, Inc. (Nasdaq: ADTX) ("Aditxt" or the "Company"), a biotech innovation company developing and commercializing technologies focused on monitoring and modulating the immune system, today provides shareholders with a corporate update following the completion of a reverse stock split and closing of a previously announced $20 million public offering.
